StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3026% below fair value
$7.31+0.37 (+5.33%)

Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –

OptimizeRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

OptimizeRx's net income for the twelve months ending Jun 30, 2026 was $4.60M. For fiscal 2025 it was $5.13M. The highest annual figure on record is $5.13M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.13M–
FY2024Dec 31, 2024-$20.11M–
FY2023Dec 31, 2023-$17.57M–
FY2022Dec 31, 2022-$11.44M-3125.4%
FY2021Dec 31, 2021$378.08K–
FY2020Dec 31, 2020-$2.21M–
FY2019Dec 31, 2019-$3.14M-1488.4%
FY2018Dec 31, 2018$226.34K–
FY2017Dec 31, 2017-$2.10M–
FY2016Dec 31, 2016-$1.54M–
FY2015Dec 31, 2015-$595.14K–
FY2014Dec 31, 2014-$1.03M–
FY2013Dec 31, 2013-$267.29K–
FY2012Dec 31, 2012-$454.55K–
FY2011Dec 31, 2011-$2.12M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$703.00K-145.9%
Q1 FY2026Mar 31, 2026-$495.00K–
Q4 FY2025Dec 31, 2025$5.02M–
Q3 FY2025Sep 30, 2025$779.00K–
Q2 FY2025Jun 30, 2025$1.53M–
Q1 FY2025Mar 31, 2025-$2.20M–
Q4 FY2024Dec 31, 2024-$78.00K–
Q3 FY2024Sep 30, 2024-$9.12M–
Q2 FY2024Jun 30, 2024-$4.01M–
Q1 FY2024Mar 31, 2024-$6.90M–
Q4 FY2023Dec 31, 2023-$4.14M–
Q3 FY2023Sep 30, 2023-$2.87M–
Q2 FY2023Jun 30, 2023-$4.16M-767.4%
Q1 FY2023Mar 31, 2023-$6.40M-16137.5%
Q4 FY2022Dec 31, 2022-$325.84K-192.5%
Q1 FY2022Mar 31, 2022-$3.76M–
Q4 FY2021Dec 31, 2021$623.46K-54.1%
Q3 FY2021Sep 30, 2021$39.89K–
Q2 FY2021Jun 30, 2021$352.10K–
Q1 FY2021Mar 31, 2021-$637.38K–
Q4 FY2020Dec 31, 2020$1.36M+233.8%
Q3 FY2020Sep 30, 2020-$282.89K-4432.9%
Q2 FY2020Jun 30, 2020-$1.08M–
Q1 FY2020Mar 31, 2020-$2.20M-999.8%
Q2 FY2019Jun 30, 2019$406.62K+45.0%
Q1 FY2019Mar 31, 2019$6.53K–
Q4 FY2018Dec 31, 2018-$109.91K–
Q3 FY2018Sep 30, 2018$244.93K–
Q2 FY2018Jun 30, 2018$280.51K–
Q1 FY2018Mar 31, 2018-$189.18K–
Q4 FY2017Dec 31, 2017-$237.06K–
Q3 FY2017Sep 30, 2017-$622.79K–
Q2 FY2017Jun 30, 2017-$361.50K–
Q1 FY2017Mar 31, 2017-$882.68K–
Q4 FY2016Dec 31, 2016-$352.75K–
Q3 FY2016Sep 30, 2016-$242.58K–
Q2 FY2016Jun 30, 2016-$591.93K–
Q1 FY2016Mar 31, 2016-$351.92K–

More OptimizeRx figures

See a number that looks wrong?